CM-579 is primarily used in research settings to study its potential therapeutic effects, particularly in the field of oncology. It has shown promise in inhibiting specific cellular pathways that are critical for cancer cell survival and proliferation. Researchers are exploring its efficacy as a targeted therapy for certain types of cancers, aiming to develop more effective and less toxic treatment options. Additionally, CM-579 is being investigated for its role in modulating immune responses, which could have implications in immunotherapy. Its application in preclinical studies helps in understanding its mechanism of action and evaluating its safety profile for potential future clinical use.